Microfluidic Point-of-Care Ecarin-Based Clotting and Chromogenic Assays for Monitoring Direct Thrombin Inhibitors.
Direct thrombin inhibitors (DTIs), such as bivalirudin and dabigatran, have maintained steady inpatient and outpatient use as substitutes for heparin and warfarin, respectively, because of their high bioavailability and relatively safe "ontherapy" range. Current clinical methods lack the capacity to...
| Publicado en: | Journal of Extra-Corporeal Technology Vol. 51; no. 1; pp. 29 - 38 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
AMSECT
Mar2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |